Related Experiment Video
Updated: Jan 4, 2026

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
Published on: February 8, 2017
Cationic phospholiposomes: efficient delivery vehicles of anticancer derivatives of ATP to multiple myeloma cells
1Department of Biochemistry, Molecular Biology and Cell Biology, Northwestern University, Evanston, Illinois 60208, USA.
Abstract:
Analogs of adenosine triphosphate (ATP) with substitutions at the 8-position have been shown to be cytotoxic to multiple myeloma, one of the most prevalent and serious blood cancers. However, these drugs do not readily cross biological membranes and are very sensitive to phosphatases present in body fluids. To circumvent these disadvantages, 8-substituted ATPs were encapsulated into cationic phospholiposomes generated from cationic phosphatidylcholines (EDOPC; 1,2-dioleoyl-sn-glycero-3-ethylphosphocholine, and EDPPC, the corresponding dipalmitoyl homolog), compounds with low toxicity that readily form liposomes. Vortexing was an efficient encapsulation procedure, more so than freeze-thawing. At the lipid:drug ratio of 5:1 (mol/mol), 20% of 8-Br-ATP was encapsulated within EDOPC liposomes. Efficient encapsulation and retention of 8-NH₂-ATP required the inclusion of cholesterol. Liposomes of EDOPC:cholesterol (55:45 mole/mole), at a lipid:drug mole ratio of 10:1, captured ~40% of the drug presented. Cytotoxicity assays of this formulation on multiple myeloma cells in culture showed encapsulated drug to be up to 10-fold more effective than free drug, depending upon dose. Intracellular distribution studies (based on fluorescent derivatives of lipids and of ATP) revealed that both liposomes and drug were taken up by multiple myeloma cells, and that uptake of a fluorescent ATP derivative was significantly greater when encapsulated than when free. Liposomes prepared from EDPPC, having a higher phase-transition temperature than EDOPC, captured 8-NH₂-ATP satisfactorily and released it more slowly than the unsaturated formulations, but were also less cytotoxic. The superior encapsulation efficiencies of the positively charged liposomes can be understood in terms of the electrostatic double layer due to a very high positive charge density on their inner surface. Electrostatic augmentation of encapsulation for small vesicles can be dramatic, easily exceeding an order of magnitude.
Insights
Encapsulating 8-substituted adenosine triphosphate (ATP) analogs into cationic liposomes enhances their delivery and efficacy against multiple myeloma. This novel approach overcomes drug limitations, improving cancer treatment potential.
Area of Science:
- Biochemistry and Molecular Biology
- Nanotechnology in Medicine
- Cancer Therapeutics
Background:
- Adenosine triphosphate (ATP) analogs with 8-position substitutions show promise as cytotoxic agents against multiple myeloma.
- Limitations include poor biological membrane permeability and sensitivity to phosphatases in bodily fluids.
- Cationic phospholiposomes offer a potential delivery vehicle to overcome these challenges.
Purpose of the Study:
- To develop and evaluate cationic liposomes for encapsulating 8-substituted ATP analogs.
- To assess the efficacy and cellular uptake of encapsulated drugs compared to free drugs.
- To investigate the role of liposome composition and preparation methods on encapsulation and drug release.
Main Methods:
- Encapsulation of 8-Br-ATP and 8-NH₂-ATP into cationic liposomes (EDOPC and EDPPC) using vortexing.
- Inclusion of cholesterol to improve encapsulation efficiency for specific analogs.
- Cytotoxicity assays on multiple myeloma cells and intracellular distribution studies using fluorescent markers.
Main Results:
- Vortexing proved more efficient than freeze-thawing for liposome encapsulation.
- EDOPC:cholesterol liposomes (55:45 mole/mole) achieved ~40% encapsulation of 8-NH₂-ATP.
- Encapsulated drug demonstrated up to 10-fold greater efficacy in multiple myeloma cell cultures.
- Liposomal encapsulation significantly increased cellular uptake of ATP analogs.
Conclusions:
- Cationic phospholiposomes effectively encapsulate 8-substituted ATP analogs, enhancing their anti-myeloma activity.
- Liposome composition, particularly cholesterol inclusion, influences encapsulation and drug retention.
- This liposomal drug delivery system presents a promising strategy for improving multiple myeloma treatment.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

